Alamar Biosciences, Inc. (California) (ALMR)
30.83
-0.93
(-2.93%)
USD |
NASDAQ |
Nov 13, 16:00
30.83
0.00 (0.00%)
After-Hours: 19:59
Alamar Biosciences Net Income (Quarterly) : -13.34M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -13.34M |
| June 30, 2026 | -13.20M |
| March 31, 2026 | -21.32M |
| Date | Value |
|---|---|
| September 30, 2025 | -8.001M |
| June 30, 2025 | -7.023M |
| March 31, 2025 | -7.659M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Personalis, Inc. | -33.80M |
| 10X Genomics, Inc. | -19.42M |
| Champions Oncology, Inc. | -0.426M |
| Medpace Holdings, Inc. | 137.46M |
| Avantor, Inc. | 203.40M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 33.54M |
| Total Expenses (Quarterly) | 46.89M |
| EPS Diluted (Quarterly) | -0.1921 |
| Enterprise Value | 2.022B |
| Gross Profit Margin (Quarterly) | 61.54% |
| Profit Margin (Quarterly) | -39.77% |
| Earnings Yield | -2.61% |
| Normalized Earnings Yield | -2.286 |